These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1105 related articles for article (PubMed ID: 25880877)

  • 1. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
    Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
    Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma.
    Lin L; Qin Y; Jin T; Liu S; Zhang S; Shen X; Lin Z
    Exp Mol Pathol; 2014 Apr; 96(2):200-5. PubMed ID: 24384455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of high NQO1 expression in breast cancers.
    Yang Y; Zhang Y; Wu Q; Cui X; Lin Z; Liu S; Chen L
    J Exp Clin Cancer Res; 2014 Feb; 33(1):14. PubMed ID: 24499631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix.
    Ma Y; Kong J; Yan G; Ren X; Jin D; Jin T; Lin L; Lin Z
    BMC Cancer; 2014 Jun; 14():414. PubMed ID: 24912939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer.
    Tong YH; Zhang B; Yan YY; Fan Y; Yu JW; Kong SS; Zhang D; Fang L; Su D; Lin NM
    Oncotarget; 2017 Jul; 8(28):45750-45758. PubMed ID: 28501854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortalin overexpression predicts poor prognosis in early stage of non-small cell lung cancer.
    Sun J; Che SL; Piao JJ; Xu M; Chen LY; Lin ZH
    Tumour Biol; 2017 Mar; 39(3):1010428317695918. PubMed ID: 28349826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.
    Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C
    BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
    Wang Y; Li N; Che S; Jin T; Piao J; Liu S; Lin Z
    Tumour Biol; 2017 Jul; 39(7):1010428317709675. PubMed ID: 28718367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
    Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
    Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
    Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
    Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAZ is an independent prognostic factor in non-small cell lung carcinoma: Elucidation at protein level.
    Malik SA; Khan MS; Dar M; Hussain MU; Mudassar S
    Cancer Biomark; 2017; 18(4):389-395. PubMed ID: 28128737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.
    Jin H; Ji M; Chen L; Liu Q; Che S; Xu M; Lin Z
    J Exp Clin Cancer Res; 2016 Mar; 35():42. PubMed ID: 26955804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
    Yan B; Zhang W; Mao XW; Jiang LY
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma].
    Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Gong J; Zhang H; He L; Wang L; Wang J
    Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.